Effectiveness of the Dynavision Device to Improve Spatial Awareness After Brain Injury

Launched by QUEEN'S UNIVERSITY · Aug 16, 2022

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a device called the Dynavision D2 to help improve spatial awareness in adults who have experienced a stroke or an acute brain injury. Specifically, the trial aims to see if using this device can help reduce a condition known as left neglect, where individuals may not pay attention to things on their left side. Participants will be divided into two groups: one group will receive standard occupational therapy (OT) for one hour each day, while the other group will have 30 minutes of standard OT and an additional 30 minutes using the Dynavision device for a total of 10 or 20 sessions, depending on their hospital stay.

To be eligible for this trial, participants must be inpatients receiving treatment for stroke or brain injury, be medically stable, and show moderate to severe left neglect as measured by a specific scale. They should also be motivated to participate in daily therapy and able to tolerate a few hours of different therapies each day. This trial is currently recruiting participants, and those involved can expect to be evaluated at the start of the study, after 10 sessions, and after 20 sessions to see how their condition improves.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Inpatient on stroke or acute brain injury service
• • Medically stable
• • Moderate-to-severe neglect, as determined by the Catherine Bergego Scale
• • Motivated to participate in daily therapy
• • Can physically and cognitively tolerate up to three hours of daily therapy from Occupational Therapy, Physiotherapy, and Speech Therapy
• Exclusion Criteria:
• • N/A